KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Current Deferred Revenue (2016 - 2021)

CareDx (CDNA) has disclosed Current Deferred Revenue for 9 consecutive years, with $4.2 million as the latest value for Q4 2021.

  • Quarterly Current Deferred Revenue rose 19.21% to $4.2 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2021, up 19.21% year-over-year, with the annual reading at $4.2 million for FY2021, 19.21% up from the prior year.
  • Current Deferred Revenue hit $4.2 million in Q4 2021 for CareDx, up from $3.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $4.2 million in Q4 2021 to a low of $39000.0 in Q2 2017.
  • Historically, Current Deferred Revenue has averaged $1.9 million across 5 years, with a median of $1.8 million in 2018.
  • Biggest five-year swings in Current Deferred Revenue: crashed 90.32% in 2018 and later soared 9351.28% in 2019.
  • Year by year, Current Deferred Revenue stood at $39000.0 in 2017, then changed by 0.0% to $39000.0 in 2018, then skyrocketed by 9351.28% to $3.7 million in 2019, then fell by 4.23% to $3.5 million in 2020, then rose by 19.21% to $4.2 million in 2021.
  • Business Quant data shows Current Deferred Revenue for CDNA at $4.2 million in Q4 2021, $3.4 million in Q3 2021, and $3.9 million in Q2 2021.